New Product - Stribild
Stribild (tenofovir disoproxil fumarate/ emtricitabine/ elvitegravir/ cobicistat) contains combination NRTIs + integrase strand transfer inhibitor (INSTI) + pharmacokinetic enhancer respectively. Stribild is indicated as a single tablet regimen for HIV infection in treatment naive adults. It is contraindicated with concomitant alfuzosin, rifampicin, ergot derivatives (eg dihydroergotamine, ergonovine, ergotamine, methylergonovine), cisapride, St John's wort, lovastatin, simvastatin, pimozide, sildenafil for PAH, oral midazolam, triazolam, other products containing same active components (tenofovir disoproxil fumarate, emtricitabine), ritonavir, lamivudine, adefovir dipivoxil. Stribild is also contraindicated in children and adolescents aged less than 18 yrs. Stribild is available as a combination tablet containing tenofovir disoproxil fumarate 300 mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg in packs of 30’s.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629